Texas Permanent School Fund increased its holdings in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 5.6% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 105,290 shares of the biopharmaceutical company’s stock after purchasing an additional 5,547 shares during the quarter. Texas Permanent School […]
